Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo pill shows promise for Binge-Eating and weight loss

NCT ID NCT03946111

First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 26 times

Summary

This study tested whether a combination of two medications (naltrexone and bupropion) can help people with binge-eating disorder and obesity reduce their binge-eating episodes and lose weight. Participants were adults aged 18 to 64 who met criteria for binge-eating disorder and had a high body mass index. The study compared the medication to a placebo in people who did not respond well to initial treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Yale Department of Psychiatry

    New Haven, Connecticut, 06510, United States

Conditions

Explore the condition pages connected to this study.